A double-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in healthy volunteers.
Diabetes Mellitus, Type 2
Phase 1
A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
June 2014